Search Results 21-30 of 16210 for anti-TNF drugs

1. A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy - Mayo Clinic

   * Must have failed anti-TNF treatment for HS. * To be eligible for the Sub-study, participants must be naïve to biologic therapy for treatment of HS.

2. Crohn's disease - Diagnosis and treatment - Mayo Clinic

   Infliximab (Remicade), adalimumab (Humira) and certolizumab pegol (Cimzia). Also known as TNF inhibitors, these medicines work by neutralizing an immune system ...

3. Ankylosing spondylitis - Diagnosis & treatment - Mayo Clinic

   If nonsteroidal anti-inflammatory drugs (NSAIDs) aren't helpful, your doctor might suggest starting a tumor necrosis factor (TNF) blocker or an interleukin-17 ( ...

4. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

   The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

5. Inflammatory Bowel Disease (IBD) Clinical Trials - Mayo Clinic Research

   The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone ...

6. Etanercept-ykro (subcutaneous route) - Mayo Clinic

   Etanercept-ykro injection is used alone or together with other medicines (eg, methotrexate) to reduce signs and symptoms of active arthritis, rheumatoid ...

7. Weekend Wellness: Ankylosing spondylitis symptom changes hard to predict

   When these symptoms are persistent, treatment usually involves medications known as TNF blockers. ... Examples of these medications include adalimumab, etanercept ...

8. Sacroiliitis - Diagnosis and treatment - Mayo Clinic

   Tumor necrosis factor (TNF) inhibitors include etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade) and golimumab (Simponi). Both types of ...

9. Infliximab (intravenous route) - Mayo Clinic

   Adalimumab; Adenovirus Vaccine Type 4, Live ... Other Interactions. Certain medicines should not ... Drugs & Supplements. Infliximab (intravenous route) ...

10. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    ... treatment with anti-TNF-alpha agents. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...